- Over two decades of expertise in developing and executing go-to-market strategic initiatives for start-up disruptive medical device companies.
- Recruited, trained, and led corporate sales teams and national distribution networks
Dr. Howard McLeod
Co-Founder & CMO
- Internationally recognized expert in precision medicine and pharmacogenomics.
- Ranked #1 in the U.S. and #2 worldwide.
- Collaborative work in over 50 countries; H-index 114.
- Over 600 peer-reviewed publications.
- Served as a member or chair of: Food and Drug Administration, National Institutes of Health, Personalized Medicine Coalition, World Health Organization (WHO), Wellcome Trust, Cancer Research UK, Genome Canada.
- Served as a Distinguished Professor of Medicine and Executive Clinical Director for over three decades (33 hospitals/400 clinics).
Dr. Daniel Rotroff
Chief Medical Informatics Officer
- Extensive expertise in using ML/AI to integrate clinical and -omics data develop tools to enable precision medicine in complex diseases.
- An NIH-funded researcher, that also serves as the Director for the Center for Quantitative Metabolic Research at the Cleveland Clinic.
- Has published >80 peer-reviewed articles on the development of biomarker signatures to predict disease or treatment response
Dr. Andrew Draper
Chief Clinical Officer
- Expert consultant specializing in optimizing mental health treatment through pharmacogenomics, nutrigenomics, and comprehensive medication management strategies.
- Established educator with over 10 years of experience teaching pharmacology and pharmacogenomics at two postgraduate university programs.
- Ambulatory care pharmacist with a focus on patient-centered care and strategies for enhancing insurance profitability
- Published researcher in preventive medicine, over-the-counter medications, and innovative teaching methods
Sandip Patel
Chief Growth Officer
Sandip has been involved in the formation, acquisition, development, growth and exit of several companies within the healthcare, insurance and financial services fields and has been
an entrepreneur for over 20 years. He has been an officer and director of several companies
which ultimately resulted into successful exits through acquisitions, mergers, and public
offerings. His current portfolio consists of investments in healthcare companies ranging from Biotech, Medical Devices and Healthcare Technology, as well as in the Financial
Services/Technology and Insurance space. These investments are made specifically where his personal involvement leads to adding substantial value to the company.